ANG1005, a novel peptide-paclitaxel conjugate crosses the BBB and shows activity in patients with recurrent CNS metastasis from breast cancer, results from a phase II clinical study

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 27; p. vi103
Main Authors	Tang, S.-C., Kumthekar, P., Brenner, A.J., Kesari, S., Piccioni, D., Anders, C.K., Carillo, J.A., Chalasani, P., Kabos, P., Puhalla, S.L., Garcia, A., Tkaczuk, K., Ahluwalia, M.S., Lakhani, N., Ibrahim, N.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2016
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdw367.02